Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01851213 · ClinicalTrials.gov registry record
FoundationOne™ Test Registry Study
A clinical trial, sponsored by Foundation Medicine.
- Completed
- Registry status
- 510
- Enrollment target
NCT01851213: Completed study, sponsored by Foundation Medicine.
NCT01851213 is a clinical trial that has completed, run by Foundation Medicine. The registered enrollment target is 510 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01851213 has completed, sponsored by Foundation Medicine.
- COMPLETED
- Registry status
- 510 participants
- Enrollment target
Study Summary
This study is a prospective, multicenter, observational study to characterize utilization patterns of the FoundationOne™ test by oncologists under conditions of routine clinical practice in the US. The study will also examine impact of test results on subsequent clinical decisions regarding choice of therapy. The planned duration of the study is at least 2 years with 1 year for patient recruitment and a minimum 1-year follow-up period for each patient. Any patient for whom the treating physician has ordered a FoundationOne™ test and a report is delivered is eligible for participation on the study. Eligible patients from participating sites will be enrolled sequentially during the 1-year enrollment period. Sites will be required to maintain an enrollment log of all patients for whom the FoundationOne™ test has been ordered and document patient disposition and reasons for non-participation. All treatment decisions and clinical assessment will be made at the discretion of the treating physician per usual care and are not mandated by study design or protocol. Informed consent will be obtained from eligible patients prior to study entry.
Primary Outcome
Characterization of practice patterns for the use of the test described by: * Provider and site characteristics of patients receiving the FoundationOne test * Socio-demographic and clinical characteristics of patients receiving the FoundationOne test Examination of the effect of the test on clinical decision making by describing: * Subsequent treatment patterns for patients after receipt of test results * Clinician report outcomes regarding how test results guided clinical decision making
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 510 participants |
| Start Date | 2013-03 |
| Est. Completion | 2016-03 |
What the finished NCT01851213 record still lists
NCT01851213 is an observational study that tracks outcomes without assigning an intervention. The registered 510 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01851213 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01851213 about?
NCT01851213 is a clinical study titled "FoundationOne™ Test Registry Study". This study is a prospective, multicenter, observational study to characterize utilization patterns of the FoundationOne™ test by oncologists under conditions of routine clinical practice in the US. The study will also examine impact of test results on subsequent clinical decisions regarding choice o...
What is the current status of trial NCT01851213?
This trial is currently completed. The enrollment target is 510 participants. The study started on 2013-03. Estimated completion is 2016-03.
Who is sponsoring clinical trial NCT01851213?
This trial is sponsored by Foundation Medicine, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03922542 · 510 participants · Phase 2
Comparison of Standard vs. Accelerated Corneal Crosslinking
- NCT04634552 · 510 participants · Phase 2
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- NCT05164744 · 510 participants
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
- NCT05451004 · 510 participants · Phase 3
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia